logo
#

Latest news with #Delta-9THC

President Trump's administration is 'looking at reclassification' of marijuana. What to know about Indiana laws
President Trump's administration is 'looking at reclassification' of marijuana. What to know about Indiana laws

Indianapolis Star

time28 minutes ago

  • Health
  • Indianapolis Star

President Trump's administration is 'looking at reclassification' of marijuana. What to know about Indiana laws

President Donald Trump said earlier this week his administration is considering reclassifying marijuana as a less dangerous drug. "We're looking at reclassification and we'll make a determination over the next few weeks," Trump said at news conference August 11. Though 45 states have legalized the use of marijuana for medicinal or recreational use, the federal government still classifies it as a Schedule I drug. Here's what a Schedule I drug is and what to know about marijuana laws in Indiana as well as around the country. Schedule I drugs are defined as highly dangerous, addictive and without medical use. Marijuana has belonged to this class of drugs since the Controlled Substances Act was signed in 1970. If reclassified, marijuana would be treated the same as drugs like Tylenol with codeine and anabolic steroids, which can be prescribed by licensed health care providers and dispensed by licensed pharmacies. Reclassifying marijuana would be the biggest change in marijuana policy the federal government has taken since the drug was first outlawed, but it would not make recreational usage legal under federal law. No. In Indiana, weed is not legal for recreational or medical use. CBD, Delta-9 THC and THCA, which are alternatives to marijuana, are available for legal purchase at vape shops in Indiana as long as those levels don't exceed the legal limit. Any THC product with a higher level than 0.3% is classified as marijuana and therefore still illegal. Cannabis cheat code: Marijuana is illegal in Indiana, but this loophole makes it complicated Marijuana is legal for both recreational and medicinal use in 24 states and the District of Columbia as of April 2025, according to DISA Global Solutions. The states are listed below: 46 states, Washington DC and three U.S. territories have approved some form of cannabis for medicinal use. Nebraska is the most recent state to vote in favor of medical marijuana. Story continues after photo gallery. Marijuana was banned federally in 1970 with the passage of the Controlled Substances Act, which classified marijuana as a Schedule I drug. More on cannabis: What's the difference between Delta 8 THC and marijuana or 'weed'? Marijuana is fully illegal for both medicinal and recreational use and has not been decriminalized in four additional states: There are also a few states where medical and recreational marijuana isn't legalized, but is decriminalized. Kayla Dwyer and Greta Cross contributed to this report.

24 states have legalized marijuana for medical and recreational use. Where does Indiana stand?
24 states have legalized marijuana for medical and recreational use. Where does Indiana stand?

Indianapolis Star

time14-07-2025

  • Health
  • Indianapolis Star

24 states have legalized marijuana for medical and recreational use. Where does Indiana stand?

In 2025, marijuana is fully legal in 24 states and Washington DC. Although the Indiana legislature once again tried this year to pass laws legalizing medical and recreational use of marijuana, just like previous attempts, those bills ultimately died by the end of the legislative session. Here's where Indiana's marijuana laws and cannabis regulations currently stand and what the laws look like in other states. No. In Indiana, weed is not legal for recreational or medical use. CBD, Delta-9 THC and THCA, which are alternatives to marijuana, are available for legal purchase at vape shops in Indiana as long as those levels don't exceed the legal limit. Any THC product with a higher level than 0.3% is classified as marijuana and therefore still illegal. Cannabis cheat code: Marijuana is illegal in Indiana, but this loophole makes it complicated Marijuana is legal for both recreational and medicinal use in 24 states and the District of Columbia as of April 2025, according to DISA Global Solutions. The states are listed below: 46 states, Washington DC and three U.S. territories have approved some form of cannabis for medicinal use. Nebraska is the most recent state to vote in favor of medical marijuana. Story continues after photo gallery. Marijuana was banned federally in 1970 with the passage of the Controlled Substances Act, which classified marijuana as a Schedule 1 drug. More on cannabis: What's the difference between Delta 8 THC and marijuana or 'weed'? Marijuana is fully illegal for both medicinal and recreational use and has not been decriminalized in four states: There are also a few states where medical and recreational marijuana isn't legalized, but is decriminalized. Kayla Dwyer and Greta Cross contributed to this report.

North America Legal Cannabis Market Size, Share, Trends and Forecast Report 2025-2033
North America Legal Cannabis Market Size, Share, Trends and Forecast Report 2025-2033

Yahoo

time10-07-2025

  • Business
  • Yahoo

North America Legal Cannabis Market Size, Share, Trends and Forecast Report 2025-2033

North America's legal cannabis market, valued at USD 44.83 Billion in 2024, is projected to reach USD 354.82 Billion by 2033, with a CAGR of 24.55%. Growth is driven by legalization, medical applications, and product diversification. U.S. and Canada lead with expanding regulatory frameworks, while technological advances in cultivation and increasing retail and online sales support market dynamics. Major players include Canopy Growth and Aurora Cannabis. North American Legal Cannabis Market Dublin, July 10, 2025 (GLOBE NEWSWIRE) -- The "North America Legal Cannabis Market Size, Share, Trends and Forecast by Products Derived, Distribution Channel, and Country, 2025-2033" has been added to offering. The North America legal cannabis market was valued at USD 44.83 Billion in 2024 and is projected to reach USD 354.82 Billion by 2033, with a compound annual growth rate of 24.55% from 2025-2033. This exponential market expansion is propelled by increasing legalization, rising medical applications, and growing consumer demand for diverse products. Advancements in regulation, investments, and technological innovations in cultivation and extraction processes are pivotal growth drivers. The U.S. and Canada are at the forefront, with state-level legalizations in the U.S. and full federal legalization in Canada fueling the market. The demand for cannabis-based pharmaceuticals is on the rise, driven by clinical research supporting therapeutic benefits for conditions like chronic pain, anxiety, and epilepsy, leading to accelerated medical adoption. A clinical trial by Johns Hopkins and Tufts University revealed that dronabinol, a synthetic cannabis pill, can reduce agitation in Alzheimer's patients by 30%, offering similar calming effects without severe side effects compared to traditional treatments. This research underscores the transformative potential of cannabis in medical treatments and is shifting public perception, leading to increased investments and product innovation. The economic advantages such as job creation and tax revenue are compelling more state governments to legalize cannabis. Product diversification is evident as edibles, beverages, and wellness products gain popularity. In September 2024, Tilray Brands unveiled plans to introduce Delta-9 THC drinks, including mocktails and seltzers, to U.S. markets, catering to diverse consumer preferences. Similarly, Seth Rogen's Houseplant launched THC-infused sparkling waters in December 2024, tapping into demand for smoke-free, low-calorie options. Technological advancements are enhancing consistency and quality in cultivation and extraction. There is a growing consumer preference for organic and sustainably sourced cannabis, prompting companies to adopt eco-friendly practices. Collaborations and investments from mainstream industries like pharmaceuticals and beverages further cement the market's growth. Key Trends: Product Diversification: The industry is experiencing significant product diversification, including edibles, cannabis-infused drinks, and topicals to cater to wellness-oriented consumers. Brands are also innovating with functional formulations combining cannabinoids with adaptogens and vitamins for stress relief, sleep, and relaxation. Rising Medical Applications: Clinical research is expanding the adoption of medical cannabis, with confirmed efficacy in managing chronic pain, epilepsy, and mental health disorders. The growing acceptance among healthcare professionals and patients is boosting demand and facilitating regulatory advancements to ensure product safety. Retail and E-Commerce Growth: The market is witnessing robust growth in retail and online sales as consumers seek convenience and access. Initiatives like DoorDash's home delivery for cannabis products respond to rising consumer demand, offering items like gummies and beverages in legally permissible states. Industry Segmentation: Analysis by product shows that marijuana remains dominant, supported by legalization and consumer demand for high-THC products. Regulated dispensaries lead in distribution channels, favored for adhering to government regulations and providing lab-tested, safe products. Competitive Landscape: The competitive landscape is characterized by product innovation, strategic partnerships, and geographic expansion. Companies focus on advanced cultivation techniques, extraction technologies, and sustainable production. Efforts to enhance testing, labeling, and consumer education underline the importance of regulatory compliance. Major Companies: 22nd Century Group, Inc. Medical Marijuana Inc. Hemp, Inc. Axim Biotechnologies, Inc. Arena Pharmaceuticals, Inc. Canopy Growth Corporation Aphria Inc. Aurora Cannabis Inc. Abcann Medicinals Inc. Key Questions Addressed: How big is the legal cannabis market in North America? What factors are driving the market growth? What is the forecast through 2033? Which segment holds the largest market share? Who are the leading market players? Key Attributes: Report Attribute Details No. of Pages 123 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $44.83 Billion Forecasted Market Value (USD) by 2033 $354.82 Billion Compound Annual Growth Rate 25.8% Regions Covered North America For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment North American Legal Cannabis Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Texas's Dan Patrick vows to keep fighting against THC after Abbott vetoes ban
Texas's Dan Patrick vows to keep fighting against THC after Abbott vetoes ban

The Hill

time24-06-2025

  • Business
  • The Hill

Texas's Dan Patrick vows to keep fighting against THC after Abbott vetoes ban

Lt. Gov. Dan Patrick (R) is vowing to keep fighting for a total THC ban in Texas after Gov. Greg Abbott (R) vetoed such a ban but signaled willingness to accept certain facets of one. In a statement Monday night, Abbott appeared open to a ban on 'synthetic' cannabinoids — an olive branch in the escalating war of words with Patrick. The statement from Abbott's office indicated his support for banning Delta-8, Delta-10 and other lab-created or modified variants of Delta-9 THC, the naturally-occurring psychoactive ingredient in cannabis, Patrick wrote on X. Patrick said his staff would collaborate with Abbott to 'quickly pass a bill to ban all synthetic THC' when the legislature returns for the special session Abbott has called for late July It marked a slight climb down from Patrick's blistering and often meandering press release on Monday, where he blasted Abbot's agenda as a proposal 'for us to legalize marijuana in Texas — by regulating it.' In that conference, Patrick reaffirmed his opposition to cannabis legalization, accusing the state's thousands of dispensaries of being fronts for drug cartels and terrorism. He also offered a personal criticism of Abbott, whom he accused of 'parachuting' in at the last minute to veto a law to which, Patrick said, he has offered no prior objection. The industry said this week it would welcome more regulations. The rift between the state's top Republicans broke out after Abbott's last minute decision Sunday to veto Senate Bill 3, a full ban of the state's multibillion dollar recreational cannabis industry. In his veto statement, Abbott argued that the law, which Patrick effectively held the legislative budget hostage to pass, was likely to be thrown out by federal judges as a direct challenge to federal supremacy on 'hemp.' While 'hemp' and 'marijuana' are effectively the same plant, hemp — a term of art for non-psychoactive cannabis — has been federally legal since 2018. The measure opened a gap in decades of federal cannabis policy through which a multibillion dollar grey-market industry has poured — with Texas as one of its key nodes. Hemp has become an imprtant cash crop in the five years since Texas set up its own program, and family farmers were a key constituency arguing against the ban and pressing Abbott for a veto. In the press conference, Patrick argued that virtually all Republicans in the state legislature had supported S.B. 3. But civil society group Texas Watch argued many had little choice. State Rep. Wes Virdell (R), who both voted for S.B. 3 and praised Abbott for the veto, acknowledged to The Texas Tribune the tough situation legislators were in. 'Folks are mad at me for voting for SB 3 and folks will be mad at me for supporting the veto,' Virdell told the Tribune. 'Unfortunately, politics is more than just policy and not everybody knows how the sausage gets made.' In his Monday press conference, Patrick insisted the ban was a matter of principle. 'I am not mad at the governor, but I am not going to legalize marijuana in Texas,' Patrick said. 'And if people want to vote me out of office, so be it.'

The Doggfather Delivers: Snoop Dogg and Death Row Records Launch TryDeathRow.com This Father's Day
The Doggfather Delivers: Snoop Dogg and Death Row Records Launch TryDeathRow.com This Father's Day

Malaysian Reserve

time15-06-2025

  • Business
  • Malaysian Reserve

The Doggfather Delivers: Snoop Dogg and Death Row Records Launch TryDeathRow.com This Father's Day

BOGOs, free shipping and the best hemp products – celebrate DoggFather's Day in Snoop style LOS ANGELES, June 15, 2025 /PRNewswire/ — This Father's Day, the Doggfather himself is giving fans the ultimate gift: the official launch of a nationwide direct-to-consumer e-commerce platform that brings the unapologetic spirit of West Coast hip-hop and cannabis culture straight to consumers nationwide. The cannabis lifestyle site marks the next evolution of Death Row Records under Snoop's creative leadership and further expands his cannabis empire. To celebrate the launch, is offering a special DoggFather's Day promotion anticipated to outlast the holiday: all products are Buy One, Get One Free, and customers receive free shipping on orders over $100. The promotion, anticipated to gives fans across the country a chance to experience Snoop's handpicked lineup of hemp-derived cannabis products. The launch of follows Snoop Dogg's 2022 acquisition of the legendary Death Row Records—the iconic label that defined a generation with artists like Dr. Dre, Tupac, and Snoop himself. Shortly after taking the reins, Snoop launched Death Row Records Cannabis, curating a premium catalog designed for both seasoned connoisseurs and the everydayers. With the debut of Snoop is expanding that vision nationwide, giving everyone access to the same high-quality cannabis products he stands behind. 'The magic of Death Row Records has always been about realness—music that spoke to the people who lived it,' said Snoop Dogg. ' builds on the brand's authenticity, culture, and connection. This is the place cannabis was meant to live.' features a premium selection of federally compliant hemp-derived products, including CBD and Delta-9 THC items personally vetted by Snoop. Only the finest buds make the cut—no seeds, no stems, no sticks—just top-shelf flower. The site will also offer beverages, edibles, and other Death Row quality offerings. Visit to explore the full collection and experience the next chapter of Death Row's legacy—where music, cannabis, and culture collide. About is the hemp lifestyle extension of Death Row Records, offering a curated selection of hemp-derived products and additional merchandise inspired by the fusion of music and cannabis culture. Founded by Snoop Dogg, delivers a premium, direct-to-consumer experience grounded in authenticity, legacy, and innovation.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store